Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCapsule Summary

• Main Authors: Cristi Cavanaugh, MHS (Author), Kate Orroth, PhD, MPH (Author), Xi Qian, PhD (Author), Pam Kumparatana, MSW, MPH (Author), Yuri Klyachkin, PhD (Author), Stephen Colgan, PhD (Author), Myriam Cordey, PhD, MPH (Author)
• Format: Book
• Published: Elsevier, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Patients with psoriasis and psoriatic arthritis have a higher prevalence of cardiometabolic comorbidities compared to the general population. Clinical data suggest apremilast may reduce weight and glycated hemoglobin (HbA1c). Objective: To describe changes in cardiometabolic parameters...